PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50125C00006OXIVAX - AOI #28: influenza vaccine — Osivax

Osivax holds $20.2M across 2 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Mar 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Osivax

Recipient

Mar 31, 2027

PoP end

$744K

Obligated

$744K

Potential

541714

NAICS

AN14

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Osivax — $90

Contract facts

NONE

Contract number75A50125C00006

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentOsivax

CAGEFBDR2

UEIM4YDKJJRJYC7

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN14

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startSep 30, 2025

PoP end (current)Mar 31, 2027

Obligated$744K

Current value$744K

Potential value$744K

OXIVAX - AOI #28: INFLUENZA VACCINE INNOVATION. ADVANCING METAGENOMIC NEXT-GENERATION SEQUENCING BASED AGNOSTIC DIAGNOSTICS FOR VIRAL PATHOGENS THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PREPARE THE IND PACKAGE FOR OVX836+SQ ADJUVANT. is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Osivax. Estimated value $744K ($744K obligated). Current period of performance ends Mar 31, 2027. Last award drew 1 bidder.

Recompete timing

Public

● Expiring in 205 days

Current PoP ends Mar 31, 2027 (205 days remaining). Agencies typically plan 12–18 months ahead — at 6.7 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Osivax — $20.2M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$20.2M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

75A50125C00008

OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A…

$19.5M

Jul 24, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50125C00006?

75A50125C00006 (OXIVAX - AOI #28: influenza vaccine) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $744K, currently held by Osivax. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50125C00006?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50125C00006 to Osivax (potential $744K).

Who is the incumbent on 75A50125C00006?

Osivax is the incumbent with $20.2M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Mar 31, 2027.

When does Osivax’s 75A50125C00006 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50125C00006 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Feb 2, 2026